Northwell
3D Printing and coronavirus testing
As mentioned by Todd Goldstein, director of design and innovation at Northwell, Yahoo Finance, “First it was the kits, then it became the reagents [in short supply], then it became the swabs. We couldn’t print the kits or the reagents. It’s tough; everyone wants the same supplies at the same time.”
The FDA is willing to discuss these and other issues with manufacturers and facilities. Entities should email COVIDManufacturing@fda.hhs.gov for more information.
How 3D-printing is playing a role in coronavirus testing
This entry was posted in "Additive Manufacturing Dynamics in 3D/4D Printing and AI Research Collaborations", "Cross-disciplinary Innovations: 3D Printing, 4D Printing, Biotechnology, and Robotics", "Evolution of Printing Technologies: Celebrating the Emergence of 3D/4D/5D Printing with Insights and Community Events", "Guidelines, Regulations, and SV3DPrinter.com Policy on Additive Manufacturing.", "Optimizing Patient Treatment with Additive Manufacturing: Exploring 3D Printing in Healthcare" and tagged 3D printing and coronavirus testing, and Parts During the COVID-19 Pandemic, FAQs on 3D Printing of Medical Devices, FDA, How 3D-printing is playing a role in coronavirus testing, Northwell, Todd Goldstein, Yahoo Finance.
